| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/16/2005 | CN1582288A Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
| 02/16/2005 | CN1582285A Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 02/16/2005 | CN1582282A Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
| 02/16/2005 | CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
| 02/16/2005 | CN1582271A Inhibitors of integrin alpha v beta 6 |
| 02/16/2005 | CN1582164A Antigen arrays for treatment of bone disease |
| 02/16/2005 | CN1582153A Use of (11beta, 17beta)-11-(1, 3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4, 9-dien-3-one in the treatment of major depressive disorder |
| 02/16/2005 | CN1582148A Derivatives of phenoxy-n-'4-(isothiazolidin-1, 1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor Xa in the treatment of thromboembolic diseases and tu |
| 02/16/2005 | CN1582147A Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 02/16/2005 | CN1580071A Looking-glass plant triterpene active placement, and its preparing method and use |
| 02/16/2005 | CN1579551A Drug giving-up medicine made-up by non-thebaica medicines |
| 02/16/2005 | CN1579543A Injection cerebrogalactoside carnosine and its preparing process |
| 02/16/2005 | CN1579519A Traditional Chinese medicine for treating headache disease |
| 02/16/2005 | CN1579510A Traditional Chinese medicine for treating encephalatrophy and cerebral hemiplegia |
| 02/16/2005 | CN1579486A Sobering tea and its preparation method |
| 02/16/2005 | CN1579475A Sucking tablet of active tuber of elevated gastrodia |
| 02/16/2005 | CN1579468A Use of narrow-leaved polygala root in preparing medicine for treating senile dementia resulted from A beta |
| 02/16/2005 | CN1579465A Medicinal composition for treating nervous system disease and its preparation method |
| 02/16/2005 | CN1579461A Anti-depression traditional medicinal composition and its preparation method |
| 02/16/2005 | CN1579448A Nasal spray for treating headache and hemicrania and its preparation method |
| 02/16/2005 | CN1579429A Pain-relieving medicine |
| 02/16/2005 | CN1579424A Prevention of disease induced by taking high phenylalanine and treatment there for |
| 02/16/2005 | CN1579420A Veal-blood protein-removed extract infusion and its preparation process |
| 02/16/2005 | CN1579414A Glossy-ganoderma-spore polysaccharide for injection and its preparation process |
| 02/16/2005 | CN1579412A Cytidine triphosphate disodium chloride injecta and its preparation process |
| 02/16/2005 | CN1579403A Composition for preventing fetus from nerviduct deformity and pregnant woman from ischemic anemia and preparation method thereof |
| 02/16/2005 | CN1579398A Xylosic alcohol nicotine tablet and its preparation method |
| 02/16/2005 | CN1579388A New use of sulpirde in pharmacy |
| 02/16/2005 | CN1579387A Extraction of protopine from plant, and its manufacture of medicinal preparation and use |
| 02/16/2005 | CN1579374A Pharmaceutical use of Resina-Ferulae extract |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189211C Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders |
| 02/16/2005 | CN1189210C Coupling object between CB and biological active peptide as well as medication usage thereof |
| 02/16/2005 | CN1189174C Pharmaceutical compositions contg. cinchonine dichlorhydrate |
| 02/16/2005 | CN1189173C Novel use of phencynonate hydrochloride |
| 02/16/2005 | CN1189170C Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
| 02/16/2005 | CN1189168C Use of (-)-(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2-diabetes, hyperlipidemia and hyperuricemia |
| 02/15/2005 | US6855834 By cyanide exchange reaction of the corresponding halo- or perfluoroalkylsulfonyl substituted citalopram derivative, film distillation |
| 02/15/2005 | US6855830 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 02/15/2005 | US6855829 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease |
| 02/15/2005 | US6855826 1,3-butadienes, perhydrobutadienes, ethylenes and ethanes as amino acid derivatives; hypotensive agents; antidiabetic agents and (pre)eclampsia treatments |
| 02/15/2005 | US6855823 Selective iGluR5 receptor antagonists |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855736 Molecular target of neurotoxicity |
| 02/15/2005 | US6855725 Excitatory amino acid receptor antagonists |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855716 Dihydropyrimidine compounds and compositions containing the same |
| 02/15/2005 | US6855711 Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators |
| 02/15/2005 | US6855709 Psychological disorders; central nervous system disorders |
| 02/15/2005 | US6855694 Prophylaxis of nervous system disorders comprising administering ubiquitin and liver extracts |
| 02/15/2005 | US6855693 Peptide for use in the treatment of cell damage caused by ischemia |
| 02/15/2005 | US6855689 Anticancer agents |
| 02/15/2005 | US6855688 ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | US6855334 Controlled delivery of active agents |
| 02/15/2005 | US6855310 Aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of acetaminophen, orphenadrine or tramadol. |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/15/2005 | CA2156821C Lidocaine aerosol anaesthetic |
| 02/15/2005 | CA2119562C Method and compositions for the treatment of cerebral palsy |
| 02/15/2005 | CA2107223C Crystalline tiagabine hydrochloride monohydrate, its preparation and use |
| 02/10/2005 | WO2005012513A1 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regenaration |
| 02/10/2005 | WO2005012311A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/10/2005 | WO2005012307A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 02/10/2005 | WO2005012282A1 Novel 2-thiosubstituted benzothiophene derivatives, method for production of and pharmaceutical compositions comprising the same |
| 02/10/2005 | WO2005012281A1 Neuroprotective benzo[1,3]oxathol-2-ones |
| 02/10/2005 | WO2005012272A1 Benzoxazepine compound |
| 02/10/2005 | WO2005012269A1 Novel azole compound |
| 02/10/2005 | WO2005012268A1 Sulfonamide derivative having isoxazole ring |
| 02/10/2005 | WO2005012266A1 (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
| 02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | WO2005012248A1 Benzylamine derivative |
| 02/10/2005 | WO2005012229A1 Novel bicyclic alkyl derivatives method for production of and pharmaceutical compositions comprising the same |
| 02/10/2005 | WO2005011736A1 Drug for preventing and/or treating alzheimer’s disease |
| 02/10/2005 | WO2005011720A1 Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury and proliferation and/or differentiation of neural stem cells in injured spinal cord |
| 02/10/2005 | WO2005011719A1 Composition for preventing or treating dementia comprising acanthopanax extract |
| 02/10/2005 | WO2005011718A1 Antistress agent |
| 02/10/2005 | WO2005011711A2 Inhalable gaseous medicine based on xenon and nitrous oxide |
| 02/10/2005 | WO2005011710A1 Per-6-aminosubstituted-deoxy-cyclodextrins to treat alzheimer’s diseases |
| 02/10/2005 | WO2005011694A1 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts |
| 02/10/2005 | WO2005011684A1 Medicaments containing derivatives of aryl (or heteroaryl) azolylcarbinols |
| 02/10/2005 | WO2005011666A1 Stable sustained release oral dosage form of gabapentin |
| 02/10/2005 | WO2004110415A3 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 02/10/2005 | WO2004105756A3 Combination comprising (a) a neuroprotecting agent and (b) an agent binding to gadph and pharmaceutical use thereof |
| 02/10/2005 | WO2004104030A3 Peptides modulating the activity of the engrailed transcription factor |
| 02/10/2005 | WO2004099191A3 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors |
| 02/10/2005 | WO2004096245A3 Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration |
| 02/10/2005 | WO2003063760A3 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 02/10/2005 | WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity |
| 02/10/2005 | US20050034182 Transgenic mouse with genome DNA sequence encoding a mutated human tau protein linked to promoter; mouse brain exhibits neurofibrillary tangles; Alzheimer*s and neurodegenerative disease |
| 02/10/2005 | US20050033067 cis-fused tetracyclic alcohol intermediates, the methanamine end-products, the methanamine end-products for use as a medicine, in particular as CNS active medicines |
| 02/10/2005 | US20050033066 Pkb-3564 substance with neovascularization inhibitory activity |
| 02/10/2005 | US20050033065 Transdermal therapeutic system which contains a D2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050033048 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |